These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9698028)

  • 61. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Current management of acute symptomatic deep vein thrombosis.
    Heit JA
    Am J Cardiovasc Drugs; 2001; 1(1):45-50. PubMed ID: 14728051
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prolonged hospitalization because of inappropriate delay of warfarin therapy in deep venous thrombosis.
    Westblom TU; Marienfeld RD
    South Med J; 1985 Oct; 78(10):1164-7. PubMed ID: 4049032
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism.
    Rosen RL
    J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetic optimisation of the treatment of deep vein thrombosis.
    Iorio A; Agnelli G
    Clin Pharmacokinet; 1997 Feb; 32(2):145-72. PubMed ID: 9068929
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A single complete ultrasound investigation of the venous network for the diagnostic management of patients with a clinically suspected first episode of deep venous thrombosis of the lower limbs.
    Elias A; Mallard L; Elias M; Alquier C; Guidolin F; Gauthier B; Viard A; Mahouin P; Vinel A; Boccalon H
    Thromb Haemost; 2003 Feb; 89(2):221-7. PubMed ID: 12574799
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preliminary results of a nonoperative approach to saphenofemoral junction thrombophlebitis.
    Ascer E; Lorensen E; Pollina RM; Gennaro M
    J Vasc Surg; 1995 Nov; 22(5):616-21. PubMed ID: 7494365
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thrombophilia as a predictor of persistent residual vein thrombosis.
    Spiezia L; Tormene D; Pesavento R; Salmaso L; Simioni P; Prandoni P
    Haematologica; 2008 Mar; 93(3):479-80. PubMed ID: 18310547
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation.
    Nielsen HK; Husted SE; Krusell LR; Fasting H; Charles P; Hansen HH
    J Intern Med; 1994 May; 235(5):457-61. PubMed ID: 8182402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors.
    Hansson PO; Sörbo J; Eriksson H
    Arch Intern Med; 2000 Mar; 160(6):769-74. PubMed ID: 10737276
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
    Hull RD; Raskob GE; Rosenbloom D; Panju AA; Brill-Edwards P; Ginsberg JS; Hirsh J; Martin GJ; Green D
    N Engl J Med; 1990 May; 322(18):1260-4. PubMed ID: 2183055
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis].
    Alonso Martínez JL; Abínzano Guillén ML; Urbieta Echezarreta MA; Annichérico Sánchez FJ; Fernández Ladrón V; García Sanchotena JL
    An Med Interna; 2008 Jan; 25(1):4-8. PubMed ID: 18377187
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A case of deep vein thrombosis in idiopathic nephrotic syndrome with resistance to activated protein C.
    Campisi S; Cavatorta F
    J Nephrol; 1998; 11(2):76-7. PubMed ID: 9589377
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.
    Schulman S; Rhedin AS; Lindmarker P; Carlsson A; Lärfars G; Nicol P; Loogna E; Svensson E; Ljungberg B; Walter H
    N Engl J Med; 1995 Jun; 332(25):1661-5. PubMed ID: 7760866
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of Direct Oral Anticoagulants and Warfarin in the Treatment of Deep Venous Thrombosis in the Chronic Phase.
    Wakakura S; Hara F; Fujino T; Hamai A; Ohara H; Kabuki T; Harada M; Ikeda T
    Int Heart J; 2018 Jan; 59(1):126-135. PubMed ID: 29279522
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis.
    Hirsch DR; Lee TH; Morrison RB; Carlson W; Goldhaber SZ
    Am Heart J; 1996 Feb; 131(2):276-80. PubMed ID: 8579021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The long-term clinical course of acute deep venous thrombosis.
    Prandoni P; Lensing AW; Cogo A; Cuppini S; Villalta S; Carta M; Cattelan AM; Polistena P; Bernardi E; Prins MH
    Ann Intern Med; 1996 Jul; 125(1):1-7. PubMed ID: 8644983
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Prospective 12-year follow-up study of clinical and hemodynamic sequelae of deep venous thromboses in patients with low risk (Zurich Study)].
    Franzeck UK; Schalch I; Jäger KA; Grimm ES; Bollinger A
    Wien Med Wochenschr; 1999; 149(2-4):78-84. PubMed ID: 10378331
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
    JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.